Reinhard Krickl

Reinhard Krickl is a seasoned executive with extensive experience in the medical technology and venture capital sectors. Currently serving as a Venture Partner and Advisor at Hadean Ventures, and Non Executive Director & Chairperson at Axem Neurotechnology, which aims to enhance post-stroke rehabilitation through innovative neurotechnology solutions. Reinhard has also held leadership roles at Phagenesis Inc. and Phagenesis Ltd., where significant advancements in neuromodulation for swallowing disorders were achieved. Additional contributions include board memberships at Austria Wirtschaftsservice and Nisonic, along with a prominent tenure at Medtronic, leading key growth initiatives in renal denervation and neuromodulation. Reinhard's educational background includes an MBA from IMD, participation in the International Directors Programme at INSEAD, and a Master of Science in Electrical and Electronics Engineering from Technische Universität Wien.